PubMed HealthSearch

PubMed · 9631994

Cutaneous pseudolymphomas.

Abstract

Cutaneous pseudolymphoma refers to a heterogeneous group of benign reactive T- or B-cell lymphoproliferative processes of diverse causes that simulate cutaneous lymphomas clinically and/or histologically. The inflammatory infiltrate is bandlike, nodular, or diffuse and is composed predominantly of lymphocytes with or without other inflammatory cells. Depending on the predominant cell type in the infiltrate, cutaneous pseudolymphomas are divided into T- and B-cell pseudolymphomas. Cutaneous T-cell pseudolymphomas include idiopathic cutaneous T-cell pseudolymphoma, lymphomatoid drug reactions, lymphomatoid contact dermatitis, persistent nodular arthropod-bite reactions, nodular scabies, actinic reticuloid, and lymphomatoid papulosis. Cutaneous B-cell pseudolymphomas include idiopathic lymphocytoma cutis, borrelial lymphocytoma cutis, tattoo-induced lymphocytoma cutis, post-zoster scar lymphocytoma cutis, and some persistent nodular arthropod-bite reactions. This review attempts to discuss current aspects of the classification, pathogenesis, clinical spectrum, histopathologic and immunohistochemical diagnosis, and laboratory investigations for clonality in the various types of cutaneous pseudolymphomas.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Ploysangam, D L Breneman, D F Mutasim. 1998. Cutaneous pseudolymphomas.. https://doi.org/10.1016/s0190-9622(98)70154-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The clinical diagnosis of deep venous thrombosis: integrating incidence, risk factors, and symptoms and signs.

Symptoms and clinical signs suggestive of deep venous thrombosis (DVT) are common and have numerous possible causes. Studies have shown that symptoms and clinical signs in themselves are inaccurate for the diagnosis of DVT. However, clinicians have other information at hand, such as data on risk factors for DVT, that may help improve their ability to predict a diagnosis of DVT in the individual patient. Epidemiological data on DVT incidence and risk factors were reviewed, as were published data on the accuracy of clinical diagnosis of DVT, with the use of both symptoms and signs in isolation and symptoms and signs combined with other clinical information in the form of clinical prediction indexes. Symptoms and clinical signs, when combined with other patient information such as the presence or absence of known risk factors for DVT, can improve clinical prediction considerably. Further study is needed to determine whether clinical prediction indexes have a role in improving the diagnostic process in patients with suspected DVT.

Diagnosis, Differential

[Hypersomnia. Investigational strategy for evaluating hypersomnia].

CLINIC AND HISTORY: Expression of hypersomnia can take on several forms: long period of nocturnal sleep, excessive diurnal somnolence or both. History taking is essential. Useful tools include standardized questionnaires and a diary of sleeping habits. Not only do they provide evidence of the hypersomnia, but also information on possible eccentric origin(s). A pathological hypothesis can then be put forward: sleep apnea syndrome, narcolepsy, idiopathic hypersomnia, or periodic movements during sleep. POLYGRAPHY: Different recording protocols have been designed to determine sleep patterns, often depending on the clinical setting. The goal is to obtain an objective confirmation of hypersomnia and demonstrate a cause. The type of recording (hour and duration of the recording, parameters monitored) depends on the information desired. Because captors themselves sometimes perturb sleep, polygraphic explorations must be adapted to each individual situation.

Diagnosis, Differential